Activity Preview


The Emerging Role of the Left Atrial Appendage in the Treatment of Atrial Fibrillation

Activity Type:

  • On-Demand

This activity has expired

Release Date: 5/31/2017

Expiration Date: 5/31/2018

  • Participation - no CE credit: 0


Expert presentations on the specific role of the left atrial appendage (LAA) in persistent and long-standing persistent atrial fibrillation and the emerging strategy of percutaneous, epicardial closure of the LAA as an adjunct procedure to PVI to improve freedom from recurrent AF success rates.


Randall J. Lee, MD, PhD – CHAIR, Professor of Medicine, University of California San Francisco, San Francisco, CA

Moussa C. Mansour, MD, Associate Professor in Medicine, Harvard Medical School, Director, Cardiac Electrophysiology Laboratory, Director, Atrial Fibrillation Program, Massachusetts General Hospital, Boston, MA

Dhanunjaya Lakkireddy, MD, FACC, FHRS, Professor of Medicine, Director, Center for Excellence in AF and Complex Arrhythmias, University of Kansas Medical Center, Kansas City, CA

Abdi Rasekh, MD, FACC, Professor of Medicine, Baylor St. Luke’s Medical Center, Houston, TX

David J. Wilber, MD, FAHA, FACC, Professor of Medicine, Co-Director, Cardiovascular Research Institute, Director, Cardiovascular Institute, Director, Division of Cardiology of Loyola University Medical Center, Loyola Medicine


Clinical Electrophysiology

Major Topic Areas

Atrial Fibrillation

Atrial Flutter